AG01EON9

887375-26-0 | Mapracorat

Chemical structure of Mapracorat, CAS 887375-26-0
AG01EON9
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 887375-26-0
Catalog Number AG01EON9(AGN-PC-0VNO17)
Chemical Name Mapracorat
IUPAC Name (2R)-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydro-1-benzofuran-7-yl)-4-methyl-2-[[(2-methylquinolin-5-yl)amino]methyl]pentan-2-ol
InChI InChI=1S/C25H26F4N2O2/c1-15-7-8-18-20(5-4-6-21(18)31-15)30-14-24(32,25(27,28)29)13-23(2,3)19-12-17(26)11-16-9-10-33-22(16)19/h4-8,11-12,30,32H,9-10,13-14H2,1-3H3/t24-/m1/s1
InChI Key VJGFOYBQOIPQFY-XMMPIXPASA-N
MDL Number MFCD19443722
Molecular Formula C25H26F4N2O2
Molecular Weight 462.4798
SMILES C(C[C@@](CNC=1C2=C(C=CC1)N=C(C)C=C2)([C@](F)(F)F)O)(C)(C)C3=C4C(=CC(F)=C3)CCO4
UNII 145V79YBVP
Synonyms
BOL 303242-X, BOL-303242-X, BOL303242-X, mapracorat, R-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methyl-5-quinolyl)amino)methyl)pentan-2-ol, ZK 245186, Mapracorat, 887375-26-0, UNII-145V79YBVP, ZK-245186, 145V79YBVP, BOL-303242-X, ZK245186, Mapracorat [USAN:INN], Mapracorat (USAN), ZK 245186, GTPL9654, SCHEMBL1877067, CHEMBL2103876, EX-A1913, DB12041, SB17318, HY-14864, CS-0003603, D10136, (2R)-1,1,1-Trifluoro-4-(5-fluoro-2,3-dihydro-1-benzofuran-7-yl)-4-methyl-2-(((2- methylquinolin-5-yl)amino)methyl)pentan-2-ol, (R)-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methylquinolin-5-yl)amino)methyl)pentan-2-ol, 7-Benzofuranpropanol, 5-fluoro-2,3-dihydro-gamma,gamma-dimethyl-alpha-(((2-methyl-5-quinolinyl)amino)methyl)-alpha-(trifluoromethyl)-, (alphaR)-, SEGRA, Intendis, Mapracorat [USAN], SEGRA, Schering AG, D01IUS, SEGRA (atopic dermatitis), Bayer, BOL-303242X, SEGRA (ophthalmic disease), Bausch & Lomb, ZK-216348, ZK-238587, ZK-245186 (ophthalmic), Bausch & Lomb, Mapracorat (ophthalmic, ocular inflammation), Mapracorat Ophthalmic Suspension, Bausch & Lomb, BOL-303242-X Ophthalmic Suspension, Bausch & Lomb, Mapracorat (dermatological, atopic dermatitis), Intendis, Mapracorat (ophthalmic, ocular inflammation), Bausch & Lomb, Suppressor of pro-inflammatory mediators (eczema), Intendis, Selective glucocorticoid receptor agonists (SEGRA), Schering AG, Selective glucocorticoid receptor agonists (dermatology), Schering AG, Selective glucocorticoid receptor agonists (SEGRA) Schering AG/AstraZeneca, Selective glucocorticoid receptor agonist (ophthalmic disease), Bausch & Lomb, Selective glucocorticoid receptor agonists (dermatological, eczema), Intendis, Selective glucocorticoid receptor agonists (SEGRA) Bayer Schering/AstraZeneca,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited